Review Article - (2011) Volume 2, Issue 4

Inhibitors of Tyrosine Kinases (TKI) and Small Interfering RNAs (siRNA) are Promising Targeted Cancer Treatments

Haakon Skogseth1*, Kåre E. Tvedt1 and Jostein Halgunset1,2
1Department of Laboratory Medicine, Children’s and Women’s Health, Faculty of Medicine, Norwegian University of Science and Technology, Trondheim, Norway
2Department of Pathology and Molecular Genetics, St. Olav’s Hospital, Trondheim, Norway
*Corresponding Author: